P53 codon 72 polymorphism association with head and neck squamous cell carcinoma

Brazilian Journal of Otorhinolaryngology

Volumn 76, Issue 3, 2010, Pages 316-320

  Mojtahedi, Zahra ^a   Hashemi, Seyed Basir ^b   Khademi, Bijan ^b   Karimi, Morteza ^b   Haghshenas, Mohammad Reza ^a   Fattahi, Mohammad Javad ^a   Ghaderi, Abbas ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Genes; Head and neck neoplasms; Prognosis; Tumor suppressor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CODON; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEAD AND NECK TUMOR; HUMAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CODON; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 79952109306     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1590/S1808-86942010000300008     Document Type: Article

References (14)

1. Hardisson D. Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2003;260:502-8. (Pubitemid 37363578)
2. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc. 2008;83:489-501. (Pubitemid 351536473)
3. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell .1997;88:323-31. (Pubitemid 27131374)
4. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9(2):95-107.
5. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092-100. (Pubitemid 29046852)
6. Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Cancer Genet Cytogenet. 2007;173:38-42. (Pubitemid 46187296)
7. Hiyama T, Yoshihara M, Tanaka S, Chayama K. Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol. 2008;32:945-73.
8. Perrone F, Mariani L, Pastore E, Orsenigo M, Suardi S, Marcomini B, et al. p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx. Cancer. 2007;109:2461-5. (Pubitemid 46906465)
9. Tandle AT, Sanghvi V, Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer. 2001;84:739-42. (Pubitemid 32275644)
10. Tu HF, Chen HW, Kao SY, Lin SC, Uu CJ, Chang KW. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol. 2008;87:243-52.
11. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett .2002;183:123-30. (Pubitemid 34628415)
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
13. Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA. p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett. 2002; 179: 175-83. (Pubitemid 34215109)
14. Beckman G, Birgander R, Själander A, Saha N, Holmberg PA, Kivela A, et al. Is p53 polymorphism maintained by natural selection?. Hum Hered. 1994;44:266-70. (Pubitemid 24229554)